Join the club for FREE to access the whole archive and other member benefits.

LIFNano Therapeutics

Company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF)

It is known that LIF (Leukaemia Inhibitory Factor) is a protein that can enable the repair of damaged neurons, and has promised the possibility of treatment for Multiple Sclerosis and other neurodegenerative diseases. The challenge has always been to find a way to deliver LIF to the precise location of the damaged neurons, and this is the basis of the LIFNano Rx breakthrough. Our research has developed a method of packaging a measured amount of LIF into tiny particles that can be delivered into the bloodstream (via injection or nasal spray), where they will circulate until they reach the blood-brain barrier. A unique antibody coating allows them to pass through this barrier exclusively and, once assembled at the treatment site, the completely inert particles will disintegrate, leaving only the LIF molecules and a small amount of water and carbon dioxide.

The LIFNano Rx system is a very elegant solution to several problems: it enables precise targeting of the treatment area – a more focused and economical approach; and it delivers the treatment in a completely clean, contaminant-free, easily reproducible molecular formula, eliminating the need for expensive and difficult cell-based treatments.

Visit website:




Details last updated 27-Sep-2019

Topics mentioned on this page:
Nanobots, Nootropics